Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 20;6(6):e606. doi: 10.1212/NXI.0000000000000606. Print 2019 Nov.

¹ From the Division of Neuroimmunology and Neuro-Infectious Diseases (P.A., S.S.M., N.V.), Department of Neurology, Massachusetts General Hospital, Boston; Department of Neurology (J.T.), University of Pennsylvania, Philadelphia; Division of Infectious Diseases (S.G.), Massachusetts General Hospital, Boston; and Division of Neuroimmunology (T.A.C.), Department of Neurology, University of Iowa. pria.anand@gmail.com.
² From the Division of Neuroimmunology and Neuro-Infectious Diseases (P.A., S.S.M., N.V.), Department of Neurology, Massachusetts General Hospital, Boston; Department of Neurology (J.T.), University of Pennsylvania, Philadelphia; Division of Infectious Diseases (S.G.), Massachusetts General Hospital, Boston; and Division of Neuroimmunology (T.A.C.), Department of Neurology, University of Iowa.

No abstract available

Publication types